Insulin is a cornerstone of treatment for patients with type 1 diabetes, essential for lowering blood glucose levels. However, if insulin doses are not appropriately matched to the body's needs, glucose levels can fall too low, resulting in hypoglycemia, a common and potentially dangerous complication of treatment. Hypoglycemia can impair thinking and cause symptoms ranging from dizziness and confusion to loss of consciousness.

Yale Researchers Identify New Strategy to Protect the Brain in Type 1 Diabetes
Yale School of Medicine

